|
Session 141
Poster Abstracts
HIV-2 Drug Resistance
Wednesday, 1-4 pm
Room: Hall B |
| 885 |
Selection of K65R Mutation in HIV-2 Patients Exposed to Abacavir
Berta Rodes*1, C Toro1, R Colombatti2, A Simon1, F Ricardi2, C Vieira2, A Coin2, and V Soriano1
1Hosp Carlos III, Madrid, Spain and 2Hosp Comunita St`Egidio, Bissau, Guinea Bissau |
| 886 |
Phenotypic Susceptibility in vitro to Raltegravir and Elvitegravir and Polymorphism of the Integrase Gene of HIV-2 Clinical Isolates
Benedicte Roquebert*1, F Damond1, G Collin1, G Peytavin1, A Benard2, S Matheron1, G Chene2, F Brun-Vezinet1, D Descamps1, and French ANRS HIV-2 cohort (ANRS CO 05 VIH-2)
1Hosp Bichat-Claude Bernard, Paris, France and 2INSERM U593, Bordeaux, France |
| 887 |
The Role of Innate Polymorphisms in Drug-selected Reverse Transcriptase Mutations in HIV-1 and HIV-2 Subtypes
Michel Ntemgwa*, B Brenner, T Toni, M Oliveira, D Moisi, B Spira, E Asahchop, J Schachter, J Martinez-Cajas, and M Wainberg
McGill Univ AIDS Ctr, Jewish Gen Hosp, Montreal, Canada |
|
